| PAMCX | PNOTX | PAMCX / PNOTX | |
| Total Expense Ratio | 1.01 | 0.66 | 153% |
| Annual Report Gross Expense Ratio | 1.01 | 0.66 | 153% |
| Fund Existence | 26 years | 8 years | - |
| Gain YTD | -1.703 | -7.965 | 21% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 2500 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 25.6B | 359M | 7,131% |
| Annual Yield % from dividends | 0.00 | 0.00 | - |
| Returns for 1 year | -3.57 | -10.32 | 35% |
| Returns for 3 years | 9.16 | 23.13 | 40% |
| Returns for 5 years | -15.24 | -25.92 | 59% |
| Returns for 10 years | 28.90 | N/A | - |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| MCYSX | 13.09 | 0.07 | +0.54% |
| NYLI Candriam Emerging Markets Eq Cl R6 | |||
| GSRCX | 11.18 | 0.05 | +0.45% |
| Goldman Sachs Rising Dividend Gr C | |||
| GSPKX | 18.31 | 0.05 | +0.27% |
| Goldman Sachs US Eq Div and Prem Instl | |||
| FESGX | 77.05 | 0.12 | +0.16% |
| First Eagle Global C | |||
| NRIIX | 22.43 | 0.03 | +0.13% |
| Nuveen Real Asset Income I | |||